What Can You Expect at the Measuring Impact in Medical Affairs Summit
The Measuring Impact in Medical Affairs Summit is your opportunity to explore how teams are demonstrating their value as Medical Affairs rapidly evolves into a strategic, impact-driven function. This one-of-a-kind meeting brings together leaders from pharma and biotech to share practical, proven approaches for building meaningful KPIs, adopting AI-enabled tools, and clearly demonstrating the real-world value of Medical Affairs activities.
Across interactive workshops, expert-led sessions, and in-depth case studies, you’ll uncover how high-performing teams:
- Capture high-quality, decision-shaping insights
- Communicate impact effectively to senior leadership
- Strengthen cross-functional alignment to deliver measurable outcomes
From Field Medical and Medical Communications to Evidence Generation and beyond, the summit highlights how every Medical Affairs subfunction can contribute to a unified, outcomes-focused strategy.
Join 50+ senior Medical Affairs professionals from organizations including Regeneron, Boehringer Ingelheim, Abbvie, Alexion, and Travere. Connect with peers, exchange best practices, and walk away with actionable frameworks you can put to work immediately.
Leave equipped to translate data, insights, and scientific engagement into demonstrable impact, and help shape the next generation of Medical Affairs excellence.
Unmissable Event Highlights
Translating Insights into Impact, Boehringer’s approach to building Practical KPI framework Across Medical Subfunctions
Boehringer Ingelheim’s Bill Tidwell and Greg Gillum share how to create fit-for-purpose KPIs that capture the unique value of Field Medical, Communications, and Evidence Generation teams, and align metrics with organizational goals to clearly demonstrate impact.
Redefining How Medical Affairs Measures Success Beyond Quantitative Measures
Sanofi’s Robert Johnson explores how to move beyond activity counts to metrics that truly reflect influence, linking Medical Affairs initiatives to clinical decisions, patient outcomes, and stronger HCP relationships.
Bridging the Gap and Turning Scientific Insights into Strategic Action
AbbVie’s Denise Briggs reveals how Medical Affairs teams can systematically capture and share insights across R&D and commercial functions — proving their strategic value through aligned objectives and measurable outcomes.
Attending Companies Include